Your browser doesn't support javascript.
loading
CRF07_BC is associated with slow HIV disease progression in Chinese patients.
Ye, Jingrong; Chen, Jing; Wang, Juan; Wang, Yuncong; Xing, Hui; Yu, Fengting; Liu, Lifeng; Han, Yang; Huang, Huihuang; Feng, Yi; Ruan, Yuhua; Zheng, Minna; Lu, Xinli; Guo, Xiaoli; Yang, Hong; Guo, Qi; Lin, Yi; Wu, Jianjun; Wu, Shouli; Tang, Yilong; Sun, Xiaoguang; Zou, Xiaobai; Yu, Guolong; Li, Jianjun; Zhou, Quanhua; Su, Ling; Zhang, Lincai; Gao, Zhan; Xin, Ruolei; He, Shufang; Xu, Conghui; Hao, Mingqiang; Hao, Yinxiao; Ren, Xianlong; Li, Jie; Bai, Lishi; Jiang, Tianjun; Zhang, Tong; Shao, Yiming; Lu, Hongyan.
Afiliação
  • Ye J; Institute for HIV/AIDS and STD Prevention and Control, Beijing Center for Disease Prevention and Control (CDC) and Beijing Research Center for Preventive Medicine, No.16, Hepingli Middle Street; Dong Chen District, Beijing, China.
  • Chen J; Institute for HIV/AIDS and STD Prevention and Control, Beijing Center for Disease Prevention and Control (CDC) and Beijing Research Center for Preventive Medicine, No.16, Hepingli Middle Street; Dong Chen District, Beijing, China.
  • Wang J; Institute for HIV/AIDS and STD Prevention and Control, Beijing Center for Disease Prevention and Control (CDC) and Beijing Research Center for Preventive Medicine, No.16, Hepingli Middle Street; Dong Chen District, Beijing, China.
  • Wang Y; Institute for HIV/AIDS and STD Prevention and Control, Beijing Center for Disease Prevention and Control (CDC) and Beijing Research Center for Preventive Medicine, No.16, Hepingli Middle Street; Dong Chen District, Beijing, China.
  • Xing H; Division of Virology and Immunology, State Key Laboratory for Infectious Disease and Prevention and Control and National Center for AIDS/STD Prevention and Control (NCAIDS), China CDC, No.155 Changbai Road, Changping District, Beijing, China. xingh@chinaaids.cn.
  • Yu F; Clinical and Research Center of Infectious Diseases, Beijing DiTan Hospital, Capital Medical University, No. 8, Jingshun East Street, Chaoyang District, Beijing, China.
  • Liu L; Center for Infectious Diseases, Beijing YouAn Hospital, Capital Medical University, No. 8 of the Xitoutiao Outside the YouAnmen, Feng Tai District, Beijing, China.
  • Han Y; Department of Infectious Disease, Peking Union Medical College Hospital, No. 1, Wangfujing Shuaifuyuan, Beijing, China.
  • Huang H; Treatment and Research Center for Infectious Diseases, The Fifth Medical Center of PLA General Hospital of China, No.100 Western 4th Ring Middle Road, Fengtai District, Beijing, China.
  • Feng Y; Division of Virology and Immunology, State Key Laboratory for Infectious Disease and Prevention and Control and National Center for AIDS/STD Prevention and Control (NCAIDS), China CDC, No.155 Changbai Road, Changping District, Beijing, China.
  • Ruan Y; Division of Virology and Immunology, State Key Laboratory for Infectious Disease and Prevention and Control and National Center for AIDS/STD Prevention and Control (NCAIDS), China CDC, No.155 Changbai Road, Changping District, Beijing, China.
  • Zheng M; Institute for HIV/AIDS and STD Prevention and Control, Tianjin CDC, No. 6 Huayue Road, Hedong District, Tianjin, China.
  • Lu X; Institute for HIV/AIDS and STD Prevention and Control, Hebei CDC, No. 97 Huaian East Road, Shijiazhuang, Hebei, China.
  • Guo X; Institute for HIV/AIDS and STD Prevention and Control, Shanxi CDC, No. 8 Xiaonanguan, Shuangta West Street, Yingze District, Taiyuan, Shanxi, China.
  • Yang H; Institute for HIV/AIDS and STD Prevention and Control, Inner Mongolia CDC, No. 50 Erdos Street, Hohhot, Inner Mongolia, China.
  • Guo Q; Institute for HIV/AIDS and STD Prevention and Control, Jilin CDC, No. 3145 Jingyang Road Changchun, Jilin, China.
  • Lin Y; Institute for HIV/AIDS and STD Prevention and Control, Shanghai CDC, No. 1380 Zhongshan West Road, Shanghai, China.
  • Wu J; Institute for HIV/AIDS and STD Prevention and Control, Anhui CDC, No. 12560 Fanhua Road, Economic and Technological Development Zone, Hefei, Anhui, China.
  • Wu S; Institute for HIV/AIDS and STD Prevention and Control, Fujian CDC, No. 76 Jintai Road, Gulou District, Fuzhou, Fujian, China.
  • Tang Y; Institute for HIV/AIDS and STD Prevention and Control, Jiangxi CDC, No. 555 Beijing East Road, Nanchang, Jiangxi, China.
  • Sun X; Institute for HIV/AIDS and STD Prevention and Control, Shandong CDC, No. 16992 Jingshi Road, Jinan, Shandong, China.
  • Zou X; Institute for HIV/AIDS and STD Prevention and Control, Hunan CDC, No. 450 Furong Middle Road, 1st Section, Changsha, Hunan, China.
  • Yu G; Institute for HIV/AIDS and STD Prevention and Control, Guangdong CDC, No. 160 Qunxian Road, Dashi Street, Panyu District, Guangzhou, Guangdong, China.
  • Li J; Institute for HIV/AIDS and STD Prevention and Control, Guangxi CDC, No. 18 Jinzhou Road Nanning, Guangxi, China.
  • Zhou Q; Institute for HIV/AIDS and STD Prevention and Control, Chongqing CDC, No. 8 Yangtze 2nd Road, Yuzhong District, Chongqing, China.
  • Su L; Institute for HIV/AIDS and STD Prevention and Control, Sichuan CDC, No. 6 Middle School Road, Chengdu, Sichuan, China.
  • Zhang L; Institute for HIV/AIDS and STD Prevention and Control, Gansu CDC, No. 310 Donggang West Road, Lanzhou, Gansu, China.
  • Gao Z; Beijing Red Cross Blood Center, No. 37 North 3rd Ring Middle Road, Haidian District, Beijing, China.
  • Xin R; Institute for HIV/AIDS and STD Prevention and Control, Beijing Center for Disease Prevention and Control (CDC) and Beijing Research Center for Preventive Medicine, No.16, Hepingli Middle Street; Dong Chen District, Beijing, China.
  • He S; Institute for HIV/AIDS and STD Prevention and Control, Beijing Center for Disease Prevention and Control (CDC) and Beijing Research Center for Preventive Medicine, No.16, Hepingli Middle Street; Dong Chen District, Beijing, China.
  • Xu C; Institute for HIV/AIDS and STD Prevention and Control, Beijing Center for Disease Prevention and Control (CDC) and Beijing Research Center for Preventive Medicine, No.16, Hepingli Middle Street; Dong Chen District, Beijing, China.
  • Hao M; Institute for HIV/AIDS and STD Prevention and Control, Beijing Center for Disease Prevention and Control (CDC) and Beijing Research Center for Preventive Medicine, No.16, Hepingli Middle Street; Dong Chen District, Beijing, China.
  • Hao Y; Institute for HIV/AIDS and STD Prevention and Control, Beijing Center for Disease Prevention and Control (CDC) and Beijing Research Center for Preventive Medicine, No.16, Hepingli Middle Street; Dong Chen District, Beijing, China.
  • Ren X; Institute for HIV/AIDS and STD Prevention and Control, Beijing Center for Disease Prevention and Control (CDC) and Beijing Research Center for Preventive Medicine, No.16, Hepingli Middle Street; Dong Chen District, Beijing, China.
  • Li J; Institute for HIV/AIDS and STD Prevention and Control, Beijing Center for Disease Prevention and Control (CDC) and Beijing Research Center for Preventive Medicine, No.16, Hepingli Middle Street; Dong Chen District, Beijing, China.
  • Bai L; Institute for HIV/AIDS and STD Prevention and Control, Beijing Center for Disease Prevention and Control (CDC) and Beijing Research Center for Preventive Medicine, No.16, Hepingli Middle Street; Dong Chen District, Beijing, China.
  • Jiang T; Treatment and Research Center for Infectious Diseases, The Fifth Medical Center of PLA General Hospital of China, No.100 Western 4th Ring Middle Road, Fengtai District, Beijing, China.
  • Zhang T; Center for Infectious Diseases, Beijing YouAn Hospital, Capital Medical University, No. 8 of the Xitoutiao Outside the YouAnmen, Feng Tai District, Beijing, China.
  • Shao Y; Division of Virology and Immunology, State Key Laboratory for Infectious Disease and Prevention and Control and National Center for AIDS/STD Prevention and Control (NCAIDS), China CDC, No.155 Changbai Road, Changping District, Beijing, China. yshao@bjmu.edu.cn.
  • Lu H; Institute for HIV/AIDS and STD Prevention and Control, Beijing Center for Disease Prevention and Control (CDC) and Beijing Research Center for Preventive Medicine, No.16, Hepingli Middle Street; Dong Chen District, Beijing, China. hongyanlu1972@sina.com.
Sci Rep ; 12(1): 3773, 2022 03 08.
Article em En | MEDLINE | ID: mdl-35260599
HIV subtypes convey important epidemiological information and possibly influence the rate of disease progression. In this study, HIV disease progression in patients infected with CRF01_AE, CRF07_BC, and subtype B was compared in the largest HIV molecular epidemiology study ever done in China. A national data set of HIV pol sequences was assembled by pooling sequences from public databases and the Beijing HIV laboratory network. Logistic regression was used to assess factors associated with the risk of AIDS at diagnosis ([AIDSAD], defined as a CD4 count < 200 cells/µL) in patients with HIV subtype B, CRF01_AE, and CRF07_BC. Of the 20,663 sequences, 9,156 (44.3%) were CRF01_AE. CRF07_BC was responsible for 28.3% of infections, followed by B (13.9%). In multivariable analysis, the risk of AIDSAD differed significantly according to HIV subtype (OR for CRF07_BC vs. B: 0.46, 95% CI 0.39─0.53), age (OR for ≥ 65 years vs. < 18 years: 4.3 95% CI 1.81─11.8), and transmission risk groups (OR for men who have sex with men vs. heterosexuals: 0.67 95% CI 0.6─0.75). These findings suggest that HIV diversity in China is constantly evolving and gaining in complexity. CRF07_BC is less pathogenic than subtype B, while CRF01_AE is as pathogenic as B.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / HIV-1 / Minorias Sexuais e de Gênero Tipo de estudo: Risk_factors_studies Limite: Aged / Humans / Male País/Região como assunto: Asia Idioma: En Revista: Sci Rep Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / HIV-1 / Minorias Sexuais e de Gênero Tipo de estudo: Risk_factors_studies Limite: Aged / Humans / Male País/Região como assunto: Asia Idioma: En Revista: Sci Rep Ano de publicação: 2022 Tipo de documento: Article